Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide product platform, announced the appointment of Pierre Legault, MBA, CPA, as a Director and Chairman of the Board of Directors.
March 18, 2019
· 3 min read